Calier
Adocam 1.5 mg/ml - 100 ml

Alleviation of inflammation and pain in dogs

Prescription required* (Exceptions apply)

Adocam is a is a pale. yellow and viscous oral suspension for dogs.

Each ml of Adocam contains:

  • Active substance:
    • Meloxicam 1.5 mg (equivalent to 0.05 mg per drop)
  • List of excipients:
    • Dispersible Cellulose
    • Sodium carmellose
    • Glycerol
    • Sorbitol, Liquid (non-crystallising)
    • Xylitol
    • Sodium Benzoate
    • Sodium dihydrogen phosphate dihydrate
    • Saccharin Sodium
    • Honey Flavour IFF RS 8008
    • Citric acid monohydrate
    • Purified Water

Indications for use of Adocam, specifying the target species:

  • Dogs:
    • Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
  • Do not use in pregnant or lactating animals.
  • Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
  • Do not use in cases of known hypersensitivity to the active substance or to any of the excipients.
  • Do not use in dogs less than 6 weeks of age.

Amounts of Adocam to be administered and administration route:

  • Shake well before use.
  • To be administered mixed with food.
  • Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
  • Particular care should be taken with regard to the accuracy of dosing.
  • The suspension can be given using either the drop dispenser (for very small breeds) or the measuring syringe provided in the package. The dispenser provides 0.05 mg meloxicam per drop (i.e. a dose of 0.1 mg meloxicam/kg body weight corresponds to 2 drops/kg body weight). The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight). Thus for the first day, twice the maintenance volume will be required.
  • A clinical response is normally seen within 3 - 4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
  • For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of the veterinary medicinal product can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.

Adocam is a is a pale. yellow and viscous oral suspension for dogs.

Each ml of Adocam contains:

  • Active substance:
    • Meloxicam 1.5 mg (equivalent to 0.05 mg per drop)
  • List of excipients:
    • Dispersible Cellulose
    • Sodium carmellose
    • Glycerol
    • Sorbitol, Liquid (non-crystallising)
    • Xylitol
    • Sodium Benzoate
    • Sodium dihydrogen phosphate dihydrate
    • Saccharin Sodium
    • Honey Flavour IFF RS 8008
    • Citric acid monohydrate
    • Purified Water

Indications for use of Adocam, specifying the target species:

  • Dogs:
    • Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
  • Do not use in pregnant or lactating animals.
  • Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
  • Do not use in cases of known hypersensitivity to the active substance or to any of the excipients.
  • Do not use in dogs less than 6 weeks of age.

Amounts of Adocam to be administered and administration route:

  • Shake well before use.
  • To be administered mixed with food.
  • Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
  • Particular care should be taken with regard to the accuracy of dosing.
  • The suspension can be given using either the drop dispenser (for very small breeds) or the measuring syringe provided in the package. The dispenser provides 0.05 mg meloxicam per drop (i.e. a dose of 0.1 mg meloxicam/kg body weight corresponds to 2 drops/kg body weight). The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight). Thus for the first day, twice the maintenance volume will be required.
  • A clinical response is normally seen within 3 - 4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
  • For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of the veterinary medicinal product can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
56.80
Order within 14h 14m 52s (before 12AM)
And receive your order
on Friday 18 October
AIR FREIGHT

Customers who buy this product, usually buy: